OM

Opaleye Management Portfolio holdings

AUM $494M
1-Year Est. Return 68.17%
This Quarter Est. Return
1 Year Est. Return
+68.17%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$681M
AUM Growth
-$84.8M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
74
New
Increased
Reduced
Closed

Top Buys

1
+$36M
2
+$12.1M
3
+$11M
4
KROS icon
Keros Therapeutics
KROS
+$9.69M
5
MGNX icon
MacroGenics
MGNX
+$9.41M

Top Sells

1
+$41.5M
2
+$21.7M
3
+$20.2M
4
CRDF icon
Cardiff Oncology
CRDF
+$10.1M
5
KALV icon
KalVista Pharmaceuticals
KALV
+$8.93M

Sector Composition

1 Healthcare 98.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
51
$1.66M 0.24%
+156,500
52
$1.29M 0.19%
+66,667
53
$1.18M 0.17%
+108,551
54
$1.17M 0.17%
3,050
-2,450
55
$1.05M 0.15%
5,525
+2,537
56
$958K 0.14%
+103,600
57
$737K 0.11%
+38,810
58
$47K 0.01%
417
59
– –
-11,250
60
– –
-31,292
61
– –
-88,300
62
– –
-470,203
63
– –
-353,000
64
– –
-4,228
65
– –
-115,000
66
– –
-387,500
67
– –
-3,171,800
68
– –
-254,000
69
– –
-959,000
70
– –
-45,459
71
– –
-350,000
72
– –
-381,900
73
– –
-704,400
74
– –
-315,550
1 2
3